BioMarin Pharmaceutical, Inc. (BMRN)
65.29
+0.62
(+0.97%)
USD |
NASDAQ |
Aug 31, 16:00
65.29
0.00 (0.00%)
After-Hours: 17:16
BioMarin Pharmaceutical Cash from Operations (Annual) : 827.99M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 827.99M |
| December 31, 2024 | 572.84M |
| December 31, 2023 | 159.26M |
| December 31, 2022 | 175.90M |
| December 31, 2021 | 304.54M |
| December 31, 2020 | 85.36M |
| December 31, 2019 | 48.26M |
| December 31, 2018 | 20.21M |
| December 31, 2017 | -8.757M |
| December 31, 2016 | -227.84M |
| December 31, 2015 | -221.85M |
| December 31, 2014 | -74.21M |
| December 31, 2013 | -59.63M |
| December 31, 2012 | 17.61M |
| December 31, 2011 | 18.75M |
| Date | Value |
|---|---|
| December 31, 2010 | 18.75M |
| December 31, 2009 | 87.73M |
| December 31, 2008 | -9.175M |
| December 31, 2007 | -34.50M |
| December 31, 2006 | -50.09M |
| December 31, 2005 | -62.68M |
| December 31, 2004 | -65.14M |
| December 31, 2003 | -74.80M |
| December 31, 2002 | -53.60M |
| December 31, 2001 | -23.06M |
| December 31, 2000 | -12.90M |
| December 31, 1999 | -12.94M |
| December 31, 1998 | -8.058M |
| December 31, 1997 | -3.086M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Incyte Corp. | 1.413B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| BridgeBio Pharma, Inc. | -445.91M |
| Ionis Pharmaceuticals, Inc. | -268.58M |